- Home
- USPH vs FNA Comparison
USPH vs FNA Comparison
Compare USPH & FNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USPH
- FNA
- Stock Information
- Founded
- USPH 1990
- FNA 2010
- Country
- USPH United States
- FNA United States
- Employees
- USPH N/A
- FNA N/A
- Industry
- USPH Medical/Nursing Services
- FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- USPH Health Care
- FNA Health Care
- Exchange
- USPH Nasdaq
- FNA Nasdaq
- Market Cap
- USPH 1.1B
- FNA 910.9M
- IPO Year
- USPH 1992
- FNA 2021
- Fundamental
- Price
- USPH $67.45
- FNA $13.09
- Analyst Decision
- USPH Strong Buy
- FNA Hold
- Analyst Count
- USPH 4
- FNA 6
- Target Price
- USPH $109.00
- FNA $14.50
- AVG Volume (30 Days)
- USPH 131.7K
- FNA 2.9M
- Earning Date
- USPH 05-06-2025
- FNA 05-07-2025
- Dividend Yield
- USPH 2.67%
- FNA N/A
- EPS Growth
- USPH 43.97
- FNA N/A
- EPS
- USPH 1.84
- FNA N/A
- Revenue
- USPH $664,433,000.00
- FNA $256,182,000.00
- Revenue This Year
- USPH $15.34
- FNA $14.88
- Revenue Next Year
- USPH $5.91
- FNA $13.92
- P/E Ratio
- USPH $36.64
- FNA N/A
- Revenue Growth
- USPH 10.99
- FNA 18.39
- 52 Week Low
- USPH $62.77
- FNA $4.65
- 52 Week High
- USPH $108.14
- FNA $13.13
- Technical
- Relative Strength Index (RSI)
- USPH 34.58
- FNA 64.55
- Support Level
- USPH $62.77
- FNA $12.98
- Resistance Level
- USPH $72.71
- FNA $13.07
- Average True Range (ATR)
- USPH 3.47
- FNA 0.06
- MACD
- USPH 0.34
- FNA -0.01
- Stochastic Oscillator
- USPH 42.51
- FNA 86.67
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
About FNA Paragon 28 Inc.
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.